Brought to you by 
Sandoz signs licensing agreement with Scripps Research Instit
13 Jul 1999
Executive Summary
Sandoz Pharmaceutical Corp. has signed a 10-year research and licensing agreement with Scripps Research Institute worth $300 million, to begin in 1997.
Deal Industry
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com